Research Brief: APL1β28—Surrogate for CNS Aβ42 Production?
an experimental AD drug on Aβ production (Bateman et al., 2009 and ARF related news story).—Esther
373 RESULTS
You searched Esther AND Landhuis
Sort By:
an experimental AD drug on Aβ production (Bateman et al., 2009 and ARF related news story).—Esther
AD/neurodegeneration.”—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2581 Alzheimer's Disease Glutamate
disorders. (see ARF related news story).—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2799
function leading to neuron dysfunction and degeneration.” (See full comment below.)—Esther Landhuis None
reactivity may help identify AD patients early (see full comment below).—Esther Landhuis None
drive up a person’s risk of developing AD at follow-up (Lobo et al., 2008).—Esther Landhuis. None
conference story).—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2683 Alzheimer's
hypothesis bears out.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2988 Alzheimer's
the ApoE4 gene.—Esther Landhuis. None http://www.alzforum.org/new/detail.asp?id=1905 Alzheimer's
“But these sorts of predictions are hazardous, because technology is improving incredibly fast.”—Esther
a dose-dependent fashion.—Esther Landhuis. This concludes our three-part series on tau news from ICAD. See Part
target is “totally different” from those of other AD drug candidates, Lipton said.—Esther Landhuis None
to make a big difference to many AD investigators studying Aβ,” he wrote.—Esther Landhuis None
roles in lysosomal degradative functions relevant to AD pathogenesis,” he wrote.—Esther Landhuis None
compartmentalization most likely to control the untoward effects of making cross β-sheet structures.”—Esther Landhuis